Top Markets
#1 0G 0G +40.03%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.89%
#3 Useless Coin Useless Coin +34.52%
#4 StonkBroker StonkBroker +33.91%
#5 SAFEcoin SAFEcoin +29.22%
#6 Arbitrum Arbitrum +28.52%
#7 Notcoin Notcoin +18.52%
#8 Full Moon Full Moon +18.20%
#9 Zora Zora +16.54%
#10 Curve DAO Curve DAO +16.02%
Coin of the day
0G 0G
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Classificação em ações #13828
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Preço da ação
$4.36
Valor de mercado
$457.32M
Variação (1 dia)
0.69%
Variação (1 ano)
289.29%
País
US
Negociar Relmada Therapeutics, Inc. (RLMD)

Categoria

Healthcare
EPS de Relmada Therapeutics, Inc. (RLMD)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Relmada Therapeutics, Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Relmada Therapeutics, Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH